AAMP Fall 2023 – Oncology Conference -- CME QUIZ AAMP Fall 2023 – Oncology Conference -- CME QUIZ Step 1 of 18 5% Name* First Last Email Address*Phone Number* FRIDAY 8:15 – 9:45 Dr. Anderson Patient Management Goals During Active Therapy & Recovery – Setting up Successful OutcomesDr. Anderson presented a model where there are potentially four phases of a cancer patient journey:* a. True b. False Dr. Anderson presented three “core areas” or foundations as:* a. IV Therapy, Colonics, Heat b. Food, Muscle, Brain c. IV Therapy, Diet, Laser d. None of these FRIDAY 10:30 – 12:00 Dr. Parmar “Clinical Pearlz” – Integrative Palliative Care & Symptom Management Dr. Parmer’s focus in this presentation was:* a. Cure of end stage disease b. Diet alone c. Appropriate palliative interventions d. Hydrotherapy Dr. Parmer discussed a clinically relevant and informed process for:* a. dealing with symptoms b. adverse events c. palliation d. all of these FRIDAY 1:45 – 2:30 Dr. Neustadt Bone Health: Accurate Assessment Negative effects on bone health are common in cancer patients.* a. True b. False In this session Dr. Neustadt discussed how:* a. Proper assessment and monitoring are key to improved quality of life. b. Assessment of bone health is not relevant to oncology c. Both A and B d. Neither A or B FRIDAY 2:30 – 3:15 Dr. Anderson Nutrient Controversy and Cancer Patients – Glutathione, Glutamine, NAD and IronIn this session, Dr. Anderson made the point that:* a. ANY dose of glutamine or glutathione is inappropriate in cancer patients b. There are absolutely no concerns dosing glutamine and glutathione in cancer patients c. He did not speak of glutamine or glutathione d. Glutamine or glutathione can be safely used in cancer patients WITH appropriate cautions and administration guidelines Dr. Anderson stated that there is NEVER a place for Iron use in an oncology patient:* a. True b. False FRIDAY 14:30 – 5:30 Dr. Neustadt Management of Treatment Induced Bone LossDr. Neustadt discussed:* a. treatment related bone loss b. factors in bone loss pathogenesis c. strategies for treatment. d. All of these In this session the main point was that bone loss in cancer is untreatable:* a. True b. False SATURDAY 8:15 – 8:45 Dr. Anderson Low Dose Naltrexone and Cancer – Immunotherapy and Prescribing UpdatesIn this update Dr. Anderson advocated, based on some data presented, for:* a. LDN doses of 15 or more milligrams in cancer patients b. Doses of under 0.5 milligrams in cancer c. Cyclic dosing in cancer d. None of these Based on this presentation, the only dose strategy for cancer is 4.5 milligrams, 7 days a week.* a. True b. False SATURDAY 8:45 – 9:45 Dr. Parmar From Fever Therapy to Modern ImmunotherapyBased on this presentation, fever has:* a. No place in immunology b. No effect on the immune system c. No data d. None of these In this session Dr. Parmar discussed:* a. the immunology of fever b. its relationship to therapeutic outcomes c. its connection to modern immunotherapy. d. All of these SATURDAY 10:30 – 11:00 Dr. Anderson Sequencing Therapies in OncologyDr. Anderson advocated in this session for:* a. Use of oxidants and antioxidants on the same day b. Use of high volume IV in renal failure c. Both of these d. Neither of these Based on his presentation, the idea of sequencing therapies should benefit cancer care:* a. True b. False SATURDAY 11:00 – 12:00 Dr. Gurm Case Management in an Integrated Oncology Clinic Part-1Dr. Gurm presented information on therapies including:* a. Hyperthermia b. Photodynamic Therapies c. Both d. Neither This presentation contained no case study:* a. True b. False SATURDAY 1:45 – 2:15 Dr. Anderson Hyperbaric Oxygen Therapy in Oncology – Dispelling Myths & Improving Outcomes Dr. Anderson stated “Hyperbaric Oxygen would possibly “spread cancer” or make it worse.”* a. True b. False Discussion regarding low versus high pressure hyperbaric interventions:* a. Related that only high pressure is effective b. Related that only low pressure is effective c. Pressure was not mentioned d. None of these SATURDAY 2:15 – 3:15 Dr. LaPorta Integrative Cancer Treatment: Exploring Botanical Isolates, Repurposed Drugs, and Vitamin C in Cancer Care Part-1Dr. LaPorta discussed practical uses of botanical isolates, including* a. curcumin b. artesunate c. astragalus d. All of these Dr. LaPorta discussed the role of high dose intravenous vitamin C in improving the quality of life for cancer patients:* a. True b. False SATURDAY 4:30 – 5:30 Dr. Gurm Case Management in an Integrated Oncology Clinic Part-2Dr. Gurm focused this presentation mainly on:* a. Single intervention cases b. No cases were discussed c. Integrative interventions in cases d. None of these This presentation contained a B-cell Lymphoma case:* a. True b. False SUNDAY 8:30 – 9:45 Dr. Parmar 10-Year observational study on modulated electrohyperthermia (mEHT) in the treatment of Stage 4 Cancers: A single-centre experienceThis presentation focused mostly on water-based heat therapies:* a. True b. False This presentation made the point that hyperthermia is:* a. Potentially helpful in multiple cancer types b. Unlikely to interfere with most chemotherapy c. Safe, when performed correctly d. All of these SUNDAY 9:45 – 10:45 Dr. Anderson Metastasis and Cachexia – Immunology and ManagementMetastatic drive is a:* a. Simple immunological response b. Complex immunological response c. This was not discussed Cachexia is just a calorie deficit:* a. True b. False SUNDAY 11:30 – 12:30 Dr. LaPorta Integrative Cancer Treatment: Exploring Botanical Isolates, Repurposed Drugs, and Vitamin C in Cancer Care Part-2Dr. LaPorta discussed cancer patients receiving palliative care and those with advanced stage 3 and 4 cancer.* a. True b. False The topic of repurposed drugs commonly used in cancer therapy:* a. Was never discussed b. Was discussed c. There are no such drugs SUNDAY 1:30 – 3:00 Dr. LaPorta An Integrative Approach to Brain CancerThis presentation was mainly focused on:* a. Glioma, grade 3 and 4 b. Tentorial metastasis c. Cavernous sinus disease d. All of these This presentation discussed:* a. the conventional treatments that have proven to be effective in treating brain cancer so far. b. new adjunctive treatments that have the potential to enhance therapy outcomes. c. natural medicine protocols that can assist in improving drug delivery across the blood-brain barrier. d. All of these SUNDAY 3:15 – 4:00 Dr. Anderson Food and Diet – A Rational Approach to the Real Cancer PatientDr. Anderson promoted one diet for all cancer patients:* a. True b. False Dr. Anderson presented a “step-wise” approach to oncology dietary intervention:* a. True b. False